Cargando…
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
PURPOSE: Standards for surgical decisions are unavailable, hence treatment decisions can be personalized, but also introduce variation in treatment and outcome. National registrations seek to monitor healthcare quality. The goal of the study is to measure between-hospital variation in risk-standardi...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700042/ https://www.ncbi.nlm.nih.gov/pubmed/31236819 http://dx.doi.org/10.1007/s11060-019-03229-5 |
_version_ | 1783444782553497600 |
---|---|
author | De Witt Hamer, Philip C. Ho, Vincent K. Y. Zwinderman, Aeilko H. Ackermans, Linda Ardon, Hilko Boomstra, Sytske Bouwknegt, Wim van den Brink, Wimar A. Dirven, Clemens M. van der Gaag, Niels A. van der Veer, Olivier Idema, Albert J. S. Kloet, Alfred Koopmans, Jan ter Laan, Mark Verstegen, Marco J. T. Wagemakers, Michiel Robe, Pierre A. J. T. |
author_facet | De Witt Hamer, Philip C. Ho, Vincent K. Y. Zwinderman, Aeilko H. Ackermans, Linda Ardon, Hilko Boomstra, Sytske Bouwknegt, Wim van den Brink, Wimar A. Dirven, Clemens M. van der Gaag, Niels A. van der Veer, Olivier Idema, Albert J. S. Kloet, Alfred Koopmans, Jan ter Laan, Mark Verstegen, Marco J. T. Wagemakers, Michiel Robe, Pierre A. J. T. |
author_sort | De Witt Hamer, Philip C. |
collection | PubMed |
description | PURPOSE: Standards for surgical decisions are unavailable, hence treatment decisions can be personalized, but also introduce variation in treatment and outcome. National registrations seek to monitor healthcare quality. The goal of the study is to measure between-hospital variation in risk-standardized survival outcome after glioblastoma surgery and to explore the association between survival and hospital characteristics in conjunction with patient-related risk factors. METHODS: Data of 2,409 adults with first-time glioblastoma surgery at 14 hospitals were obtained from a comprehensive, prospective population-based Quality Registry Neuro Surgery in The Netherlands between 2011 and 2014. We compared the observed survival with patient-specific risk-standardized expected early (30-day) mortality and late (2-year) survival, based on age, performance, and treatment year. We analyzed funnel plots, logistic regression and proportional hazards models. RESULTS: Overall 30-day mortality was 5.2% and overall 2-year survival was 13.5%. Median survival varied between 4.8 and 14.9 months among hospitals, and biopsy percentages ranged between 16 and 73%. One hospital had lower than expected early mortality, and four hospitals had lower than expected late survival. Higher case volume was related with lower early mortality (P = 0.031). Patient-related risk factors (lower age; better performance; more recent years of treatment) were significantly associated with longer overall survival. Of the hospital characteristics, longer overall survival was associated with lower biopsy percentage (HR 2.09, 1.34–3.26, P = 0.001), and not with academic setting, nor with case volume. CONCLUSIONS: Hospitals vary more in late survival than early mortality after glioblastoma surgery. Widely varying biopsy percentages indicate treatment variation. Patient-related factors have a stronger association with overall survival than hospital-related factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11060-019-03229-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6700042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-67000422019-08-29 Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery De Witt Hamer, Philip C. Ho, Vincent K. Y. Zwinderman, Aeilko H. Ackermans, Linda Ardon, Hilko Boomstra, Sytske Bouwknegt, Wim van den Brink, Wimar A. Dirven, Clemens M. van der Gaag, Niels A. van der Veer, Olivier Idema, Albert J. S. Kloet, Alfred Koopmans, Jan ter Laan, Mark Verstegen, Marco J. T. Wagemakers, Michiel Robe, Pierre A. J. T. J Neurooncol Clinical Study PURPOSE: Standards for surgical decisions are unavailable, hence treatment decisions can be personalized, but also introduce variation in treatment and outcome. National registrations seek to monitor healthcare quality. The goal of the study is to measure between-hospital variation in risk-standardized survival outcome after glioblastoma surgery and to explore the association between survival and hospital characteristics in conjunction with patient-related risk factors. METHODS: Data of 2,409 adults with first-time glioblastoma surgery at 14 hospitals were obtained from a comprehensive, prospective population-based Quality Registry Neuro Surgery in The Netherlands between 2011 and 2014. We compared the observed survival with patient-specific risk-standardized expected early (30-day) mortality and late (2-year) survival, based on age, performance, and treatment year. We analyzed funnel plots, logistic regression and proportional hazards models. RESULTS: Overall 30-day mortality was 5.2% and overall 2-year survival was 13.5%. Median survival varied between 4.8 and 14.9 months among hospitals, and biopsy percentages ranged between 16 and 73%. One hospital had lower than expected early mortality, and four hospitals had lower than expected late survival. Higher case volume was related with lower early mortality (P = 0.031). Patient-related risk factors (lower age; better performance; more recent years of treatment) were significantly associated with longer overall survival. Of the hospital characteristics, longer overall survival was associated with lower biopsy percentage (HR 2.09, 1.34–3.26, P = 0.001), and not with academic setting, nor with case volume. CONCLUSIONS: Hospitals vary more in late survival than early mortality after glioblastoma surgery. Widely varying biopsy percentages indicate treatment variation. Patient-related factors have a stronger association with overall survival than hospital-related factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11060-019-03229-5) contains supplementary material, which is available to authorized users. Springer US 2019-06-24 2019 /pmc/articles/PMC6700042/ /pubmed/31236819 http://dx.doi.org/10.1007/s11060-019-03229-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Clinical Study De Witt Hamer, Philip C. Ho, Vincent K. Y. Zwinderman, Aeilko H. Ackermans, Linda Ardon, Hilko Boomstra, Sytske Bouwknegt, Wim van den Brink, Wimar A. Dirven, Clemens M. van der Gaag, Niels A. van der Veer, Olivier Idema, Albert J. S. Kloet, Alfred Koopmans, Jan ter Laan, Mark Verstegen, Marco J. T. Wagemakers, Michiel Robe, Pierre A. J. T. Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery |
title | Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery |
title_full | Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery |
title_fullStr | Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery |
title_full_unstemmed | Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery |
title_short | Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery |
title_sort | between-hospital variation in mortality and survival after glioblastoma surgery in the dutch quality registry for neuro surgery |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700042/ https://www.ncbi.nlm.nih.gov/pubmed/31236819 http://dx.doi.org/10.1007/s11060-019-03229-5 |
work_keys_str_mv | AT dewitthamerphilipc betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT hovincentky betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT zwindermanaeilkoh betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT ackermanslinda betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT ardonhilko betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT boomstrasytske betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT bouwknegtwim betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT vandenbrinkwimara betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT dirvenclemensm betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT vandergaagnielsa betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT vanderveerolivier betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT idemaalbertjs betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT kloetalfred betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT koopmansjan betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT terlaanmark betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT verstegenmarcojt betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT wagemakersmichiel betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT robepierreajt betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery AT betweenhospitalvariationinmortalityandsurvivalafterglioblastomasurgeryinthedutchqualityregistryforneurosurgery |